Emmeline Ventures

About The Fund

Emmeline Ventures is an investment fund that primarily focuses on funding ambitious companies within the BioTech, HealthTech, Fitness, Medical Devices, Hospital Services, Healthcare, Wellness, and Consumer sectors. They embrace an investment thesis that seeks to refresh the system by backing startups that can create substantial change, especially in terms of inclusion and diversity. With minimum investments starting at $100,000 and a maximum cap of $5,000,000, their sweet spot for investments lies at around $1,500,000, focusing mainly on Seed and Series A funding rounds. The fund champions operational excellence, impact-focused approaches, and stays heart-centered and world-class in its operations. La Keisha Landrum Pierre, a co-founder with a track record of infusing operational excellence into impact-focused companies, believes in creating actionable solutions for complex business challenges. Naseem Sayani, another co-founder, offers a strategic and analytical perspective, leveraging trends and insights to develop creative solutions, and emphasizes a human-centric approach in technology and business building. Azin Radsan van Alebeek brings her experience as an executive and educator, focusing on financial sovereignty for women and advocating out-of-the-box thinking. The diverse team of advisors, including Dr. Gary Fraser, Senofer Mendoza, and Kaitlyn Tregenza, contributes a wealth of expertise from business development, leadership in diversity and inclusion, and a dedication to improving women's lives and health. Emphasizing the need to redefine baselines and empower founders, Emmeline Ventures strives to break cycles with their support and investment strategy, enabling founders to deliver outcomes and create outsized impact.